Darifenacin

FDA Approved: * July 28, 2017
Pharm Company: * MACLEODS PHARMS LTD
Category: Urinary System

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Darifenacin Overview

Darifenacin (trade name Enablex in US and Canada, Emselex in Europe) is a medication used to treat urinary incontinence. It was discovered by scientists at the Pfizer research site in Sandwich, UK under the identifier UK-88,525 and used to be marketed by Novartis. In 2010 the US rights were sold to Warner Chilcott for 400 million US$. Contents 1 Mechanism of action 2 Clinical uses 3 References 4 External links Mechanism of action Darifenacin works by blocking the M3 muscarinic acetyl...

Read more Darifenacin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Darifenacin

Recent Darifenacin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Darifenacin
  • Tablet, Extended Release: 15mg, 7.5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Darifenacin: (22 results)

Showing the first 20, Sorted by National Drug Code
  • 0591-4375 Darifenacin 7.5 mg Oral Tablet, Extended Release by Actavis Pharma, Inc.
  • 0591-4380 Darifenacin 15 mg Oral Tablet, Extended Release by Actavis Pharma, Inc.
  • 10370-170 Darifenacin Hydrobromide Extended-release 7.5 mg Oral Tablet, Extended Release by Par Pharmaceutical
  • 10370-171 Darifenacin Hydrobromide Extended-release 15 mg Oral Tablet, Extended Release by Par Pharmaceutical
  • 13668-202 Darifenacin 7.5 mg Oral Tablet, Extended Release by Torrent Pharmaceuticals Limited
  • 13668-203 Darifenacin 15 mg Oral Tablet, Extended Release by Torrent Pharmaceuticals Limited
  • 33342-276 Darifenacin 7.5 mg Oral Tablet, Extended Release by Macleods Pharmaceuticals Limited
  • 33342-277 Darifenacin 15 mg Oral Tablet, Extended Release by Macleods Pharmaceuticals Limited
  • 42291-206 Darifenacin Hydrobromide Extended-release 7.5 mg Oral Tablet, Extended Release by Avkare, Inc.
  • 42291-207 Darifenacin Hydrobromide Extended-release 15 mg Oral Tablet, Extended Release by Avkare, Inc.
  • 46708-223 Darifenacin 7.5 mg Oral Tablet, Extended Release by Alembic Pharmaceuticals Limited
  • 46708-224 Darifenacin 15 mg Oral Tablet, Extended Release by Alembic Pharmaceuticals Limited
  • 59746-516 Darifenacin 7.5 mg Oral Tablet, Extended Release by Jubilant Cadista Pharmaceuticals Inc.
  • 59746-517 Darifenacin 15 mg Oral Tablet, Extended Release by Jubilant Cadista Pharmaceuticals Inc.
  • 60429-850 Darifenacin Hydrobromide Extended-release 7.5 mg Oral Tablet, Extended Release by Golden State Medical Supply, Inc.
  • 60429-851 Darifenacin Hydrobromide Extended-release 15 mg Oral Tablet, Extended Release by Golden State Medical Supply, Inc.
  • 62332-223 Darifenacin 7.5 mg Oral Tablet, Extended Release by Alembic Pharmaceuticals Inc.
  • 62332-224 Darifenacin 15 mg Oral Tablet, Extended Release by Alembic Pharmaceuticals Inc.
  • 65862-861 Darifenacin 7.5 mg Oral Tablet, Film Coated, Extended Release by Aurobindo Pharma Limited
  • 65862-862 Darifenacin 15 mg Oral Tablet, Film Coated, Extended Release by Aurobindo Pharma Limited
  • 2 more results ...

Other drugs which contain Darifenacin or a similar ingredient: (1 result)

Related Darifenacin Topics:

drug darifenacin
is the drug derifenacin useful in chronic cystitis...
Enablex-darifenacin
Prostate Condition...




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA